Research Scientist, in vivo Pharmacology-Oncology
Novartis · Cambridge (USA) · Global
Other
–
Not yet analysed
Demand65
Career growth60
Healthcare fit30
Remote potential5
5-year outlook
Likely competitive within pharma R&D for PhD-level scientists, with growth tied to oncology pipeline strength and lab leadership; exact pay depends on location, degree, and experience.
Clinical license
Not required
Applicant reach
narrow
Seniority
mid
Employment type
–
Date found
2026-10-24
Intelligence details
Flexible work details
- Eligible countries
- United States
Eligibility, licensing, and location restrictions can change. Always confirm details on the source posting before applying.
Why this is worth applying to
Worth considering only if you have strong preclinical oncology or in vivo pharmacology research experience; most clinicians without wet-lab PhD training will not be competitive.
Who should apply
Physician-scientists or PhD-trained healthcare graduates with in vivo oncology pharmacology, animal-model, and drug-discovery experience; research-focused clinicians with translational oncology backgrounds may be adjacent but need clear lab evidence.
CV angle
Emphasize real preclinical research experience: in vivo oncology models, experimental design, PK/PD, data analysis, publications, cross-functional collaboration, and any drug-discovery or translational oncology work. Do not reframe clinical duties as laboratory experience.
Skills to highlight
- In vivo pharmacology
- Oncology animal models
- Preclinical drug discovery
- Experimental design
- PK/PD analysis
- Data analysis
- Translational oncology
- Cross-functional collaboration
Role summary
Preclinical pharma R&D scientist role running in vivo pharmacology experiments in oncology to support drug discovery and development.
We publish our own intelligence summary, never the full job description. Always confirm details with the employer when you apply.